Advertisement.

PRME Projected Dividend Yield

Prime Medicine Inc ( NASDAQ : PRME )

Prime Medicine is a biotechnology company committed to delivering a class of differentiated one-time curative genetic therapies, Prime Editors, to address a spectrum of diseases by deploying Prime Editing technology. Co.'s in-licensed Prime Editing technology has the ability to repair mutations. Prime Editors have two main components that act together to edit deoxyribonucleic acid (DNA): a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme, and a pegRNA, that targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence.

19 YEAR PERFORMANCE RESULTS

PRME Dividend History Detail
PRME Dividend News
PRME Competitors News

# of Shares: 0

Closing Price: 2.88

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2015	0.09	0%	0	$ 0.00	0.00%
2016	1.08	1,144%	0	$ 0.00	0.00%
2017	1.07	0%	0	$ 0.00	0.00%
2018	0.60	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2019	Sep 09, 2019	Sep 10, 2019	Sep 11, 2019	Sep 12, 2019	0.8000
2019	Jun 13, 2019	Jun 14, 2019	Jun 17, 2019	Jun 28, 2019	0.2000
2019 Total:					1.0000